7
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      SARS‐CoV‐2, skin lesions and the need of a multidisciplinary approach

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          COVID‐19 is a disease caused by severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus (SARS‐CoV‐2). It was first described in Wuhan (China) on December 2019 and has spread to become a pandemic. Its clinical presentation is mainly characterized by cough, fever and dyspnea, although many other symptoms have been described within its presentation pattern. In some cases, it causes an acute respiratory distress that has lead to the death of thousands of people around the world. Furthermore, different types of skin lesions have been described during the infection period of illness.1 In this exceptional situation of global health emergency, physicians are undertaking research work in order to achieve notions on the etiopathogenesis of these skin lesions. The first report of cutaneous manifestations described different forms of skin lesions such as erythematous rash, urticaria and chicken‐pox‐like vesicles.2 Further studies have classified 5 different type of skin lesions, and associated them with patient demographics, timing in relation to symptoms of the disease, severity and prognosis.

          Related collections

          Author and article information

          Contributors
          dgolano@yahoo.es
          Journal
          J Eur Acad Dermatol Venereol
          J Eur Acad Dermatol Venereol
          10.1111/(ISSN)1468-3083
          JDV
          Journal of the European Academy of Dermatology and Venereology
          John Wiley and Sons Inc. (Hoboken )
          0926-9959
          1468-3083
          13 June 2020
          Affiliations
          [ 1 ] Allergology Department Hospital Universitario Ramón y Cajal IRYCS Madrid Spain
          [ 2 ] Dermatology Department Hospital Universitario Ramón y Cajal IRYCS Madrid Spain
          [ 3 ] Immunology Department Hospital Universitario Ramóny Cajal IRYCS Madrid Spain
          [ 4 ] Pathological Anatomy Hospital Universitario Ramón y Cajal IRYCS Madrid Spain
          [ 5 ] Spanish Thematic Network and Co‐operative Research Centres ARADyAL Spain
          Author notes
          [* ] Corresponding author: David González‐de‐Olano

          Allergology Department, Hospital Universitario Ramón y Cajal, Carretera Colmenar Viejo km 9.100, 28034 Madrid, Spain

          Email: dgolano@ 123456yahoo.es

          [†]

          Both authors have equally contributed and should be both considered as first authors

          [‡]

          Both authors should be considered as senior authors.

          Article
          JDV16745
          10.1111/jdv.16745
          7323150
          32535943
          This article is protected by copyright. All rights reserved.

          This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

          Page count
          Figures: 0, Tables: 0, Pages: 9, Words: 322
          Product
          Categories
          Letter to Editor
          Letter to Editor
          Custom metadata
          2.0
          accepted-manuscript
          Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:29.06.2020

          Dermatology

          allergy, covid‐19, multidisciplinary, sars‐cov‐2, skin lesions

          Comments

          Comment on this article